Skip to main navigation Skip to search Skip to main content

A Rollover Study for Subjects Continuing Treatment with Open-Label Capravirine Who Were Enrolled in Study A4311002

Project: Research

Project Details

StatusFinished
Effective start/end date01/5/04 → 01/4/08

Funding

  • Pfizer Incorporated: $2,790.00